Viewing Study NCT00248534


Ignite Creation Date: 2025-12-25 @ 2:27 AM
Ignite Modification Date: 2026-01-07 @ 9:29 PM
Study NCT ID: NCT00248534
Status: TERMINATED
Last Update Posted: 2018-09-04
First Post: 2005-11-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma
Sponsor:
Organization: